High level cytokine production with enhanced cell viability

Details for Australian Patent Application No. 2002245326 (hide)

Owner GENETROL BIOTHERAPEUTICS, INC.

Inventors Lau, Allan, S.; Ossina, Natalya; Kiefer, Michael, C.; Browning, Laura

Agent FB Rice

Pub. Number AU-A-2002245326

PCT Pub. Number WO2002/059281

Priority 09/772,109 26.01.01 US

Filing date 25 January 2002

Wipo publication date 6 August 2002

International Classifications

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 005/02 Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C07K 014/47 Peptides having more than 20 amino acids

C07K 014/52 Peptides having more than 20 amino acids

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002245326

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002245327-TRANSMISSION AND RECEPTION OF DUOBINARY MULTILEVEL PULSE-AMPLITUDE-MODULATED OPTICAL SIGNALS USING FINITESTATE MACHIEN-BASED ENCODER

2002245325-METHOD OF FABRICATION TO SHARPEN CORNERS OF YBRANCHES IN INTEGRATED OPTICAL COMPONENTS AND OTHER MICRO-DEVICES